Measles is an acute infectious disease caused by the measles virus, a member of the Morbillivirus genus and family Paramyxoviridae. The disease is spread through the air, making it highly contagious. The main symptoms of measles include fever, cough, conjunctivitis, and a characteristic skin rash that begins on the face and spreads down the body. Measles can lead to serious complications such as pneumonia, encephalitis, and even death, especially in children. Vaccination against measles using a live attenuated vaccine has significantly reduced the incidence and mortality of this disease in recent decades.
History of the disease and interesting historical facts
Measles has been known to mankind for centuries, and its descriptions can be found in medical texts dating back to ancient times. The first mention of measles can be traced back to the 8th century, when Arab doctors began studying various infections. In 1760, measles was first described as an independent disease by the Scottish physician John Sanders. In the 19th century, significant outbreaks of measles were recorded, which led to improved surveillance and control of the disease. In 1963, the first measles vaccine was developed, which was a turning point in the prevention of this disease. As a result of vaccination, it has become possible to significantly reduce the incidence of the disease since the 1980s.
Epidemiology
Measles remains a major public health problem worldwide. According to the World Health Organization (WHO), more than 365,000 cases of measles were reported globally in 2019. There are significant regional differences in the incidence of the disease. For example, countries with high vaccination rates have low incidence rates, while countries with low vaccination coverage experience outbreaks. In 2020, despite the COVID-19 pandemic, measles cases have increased again, highlighting the importance of maintaining high vaccination rates.
Genetic predisposition to this disease
There is currently insufficient information about genetic susceptibility to measles, as the disease is caused by a viral infection. However, people with weakened immune systems and those with genetic disorders that affect the immune system have a significantly increased risk of developing severe measles. In some rare cases, mutations have been identified in genes involved in the immune response, which may contribute to a more severe course of the disease.
Risk factors for the development of this disease
Risk factors for measles can be divided into the following categories:
- Physical factors: insufficient vaccination, close contact with infected people, movement to regions with high incidence rates.
- Chemical factors: lack of access to adequate medical care and vaccinations.
- Social factors: low level of education, lack of awareness of the importance of vaccination, poverty.
All these aspects increase the likelihood of measles outbreaks and make disease control more difficult.
Diagnosis of this disease
Diagnosis of measles is based on clinical signs and laboratory tests. The main symptoms include:
- Fever
- Cough
- Conjunctivitis
- Rash
Laboratory testing includes serologic determination of IgM antibodies to measles virus and detection of virus in biopsy specimens or nasopharyngeal secretions. Radiologic examinations may be used to diagnose complications such as pneumonia. It is important to differentiate diseases that cause similar symptoms, such as rubella and infectious mononucleosis.
Treatment
Treatment of measles is mainly symptomatic, as antiviral drugs against the measles virus have not been developed. The main approaches include:
- General treatment: supportive therapy (drink plenty of fluids, antihistamines to relieve symptoms).
- Pharmacological treatment: use of antipyretic and analgesic drugs to improve well-being.
- Surgical treatment: not used in case of measles.
- Other treatments: Complications such as pneumonia may require hospitalization and antibiotic therapy.
List of medications used to treat this disease
The main groups of drugs used for measles:
- Antipyretic drugs (paracetamol, ibuprofen)
- Antihistamines (loratadine, cetirizine)
- Antibiotics for the treatment of bacterial complications (amoxicillin, azithromycin)
There is no specific treatment for the measles virus itself, so the emphasis is on supportive care and monitoring for complications.
Disease monitoring
Monitoring measles disease involves several key steps:
- Monitoring the patient's condition during illness and after recovery.
- Assess the duration and severity of symptoms.
- Analysis of the possibility of complications such as pneumonia and encephalitis.
The prognosis for measles is usually good in the absence of complications, but it should be taken into account that the risk of an unfavorable outcome increases in young children and individuals with weakened immune systems.
Age-related features of the disease
Measles can progress differently depending on the age group:
- In infants: The disease may be more dangerous due to an immature immune system and increased risk of complications.
- In children aged 1-5 years: severe course, often associated with pneumonia.
- In adults: increased risk of serious complications such as encephalitis.
Vaccination is a critical preventive measure to protect all age groups from the disease.
Questions and Answers
- How is measles transmitted? Measles is transmitted by airborne droplets from infected people.
- What are the main symptoms of measles? Symptoms include fever, cough, conjunctivitis and a rash starting on the face.
- Is there a vaccine for measles? Yes, there is a live attenuated vaccine that is effective in preventing the disease.
- What complications can arise from measles? Complications such as pneumonia, encephalitis and diarrhea may occur.
- What are the chances of recovery from measles? In the absence of serious complications, the chances of a full recovery are very high.
Attention to prevention and timely vaccination are key aspects in the fight against measles and preventing outbreaks of this disease.
